Abbott Laboratories

Abbott Laboratories

HQ Country
United States
Sub Divisions
フィルター:
Abbott Laboratories
Company
Topic
Show
 
2026
5 Oct 2026

Sava Technologies

4 Aug 2026

How CGMs are Riding the GLP-1 Wave to Transform Metabolic Health

The healthcare landscape is undergoing its most seismic shift in a generation. The catalyst is the explosive rise of GLP-1 receptor agonists like semaglutide and tirzepatide. Originally developed for type 2 diabetes, these medications have transformed into global blockbusters for weight management and metabolic health.
23 Jul 2026

Diabetes Management Technologies 2027-2037: Markets, Players, and Forecasts

IDTechEx Report: Dr Emma Harrop
16 Jun 2026

FDA Approval of Glucose Monitor Explodes New Over-the-Counter Market

A metabolic crisis is quietly sweeping through American youths, transforming paediatric prediabetes into one of the country's most urgent health emergencies. Recognising the acute need for accessible intervention, the U.S. Food and Drug Administration (FDA) achieved a historic milestone by expanding the clearance of Dexcom's Stelo Glucose Biosensor System for paediatric use without a prescription.
1 Jun 2026

Roche Diabetes Care

31 May 2026

Insulet

Insulet is a US-based medical device company that develops and sells a wearable and tubeless infusion pump. The company has commercialized the Omnipod series of insulin patch pumps.
31 May 2026

CamDiab

CamDiab Ltd is a UK-based startup that has developed the CamAPS FX, a smartphone app for hybrid closed-loop adjustment of insulin for people with Type 1 diabetes. A key player in the automated insulin delivery (AID) market.
28 May 2026

MiniMed

MiniMed is an independent, newly public medical technology company that leverages advanced, AI-driven closed-loop systems and a high-margin recurring consumable model to automate global diabetes management.
28 May 2026

Dexcom

Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
17 May 2026

Abbott Diabetes Care

Abbott Diabetes Care is a division of American multinational company Abbott Laboratories. Today, Abbott Diabetes Care is a major player in the continuous glucose monitoring market — the company's "Freestyle" brand of continuous glucose monitors (CGMs) is believed to be the most widely used CGM device.
Included are:
15 May 2026

Sinocare Inc

The largest individual funding stakeholder, directly controlling 25.8% of the company's equity
2025
24 Nov 2025

Sensor Market 2026-2036: Technologies, Trends, Players, Forecasts

IDTechEx Report: Mika Takahashi, Dr Conor O'Brien, Noah El Alami, Daniel Parr, Shihao Fu, Dr Yu-Han Chang and Dr Xiaoxi He
28 Feb 2025

Trends In Artificial Pancreas Technologies And Future Directions

Diabetes is a chronic condition that affects millions of people worldwide. The condition requires close and careful management to avoid severe health consequences. Today, people with diabetes have access to sophisticated automated insulin dosing (AID) systems that help in many aspects of diabetes management. IDTechEx forecasts that with further developments in AID systems, the diabetes management market can reach US$44 billion by 2035.
20 Jan 2025

Insulin Delivery

Innovation map for insulin delivery.
20 Jan 2025

Continuous Glucose Monitoring

Innovation map of continuous glucose monitoring.
14 Jan 2025

Blood Glucose Sensing

Innovation map of blood glucose sensing.
2024
20 Nov 2024

Wearable Sensors Market 2025-2035: Technologies, Trends, Players, Forecasts

IDTechEx Report:
4 Nov 2024

CamDiab

CamDiab Ltd is a UK-based startup that has developed the CamAPS FX, a smartphone app for hybrid closed-loop adjustment of insulin for people with Type 1 diabetes.
31 Oct 2024

SOOIL Development

SOOIL is a Korean medical device company focusing on diabetes management technology. The company sells the DANA series of insulin pumps.
28 Oct 2024

Senseonics